Answers are grounded in this paper and cite their sources.
Bacterial genotoxins, Cytolethal Distending Toxin (CDT) and colibactin, cause DNA damage in intoxicated epithelial cells of the host. DNA damage influences β‑catenin signaling, altering its stability and nuclear translocation, potentially contributing to cancer development. Using non-transformed hepatocytes and cancer-derived intestinal and hepatic epithelial cell lines, we showed that CDT/CdtB induces the phosphorylation of β‑catenin at serine 552, along with the loss of β‑catenin from adherens junctions. This leads to the subsequent cytoplasmic accumulation and nuclear translocation of β‑catenin, ultimately driving TCF/LEF transcription, the crucial downstream event of Wnt/β‑catenin signaling, as well as the transcription of some β‑catenin target genes. Colibactin induces similar effects. MK‑2206, a direct AKT inhibitor, and metformin, a common diabetes drug that indirectly inhibits AKT, both protected cells against various effects induced by CdtB exposure. These effects include β‑catenin phosphorylation at Ser552, the disassembly of cell-cell junctions and the subsequent nuclear accumulation of phosphorylated β‑catenin, leading to enhanced TCF/LEF-mediated transcription—early molecular shifts driving the epithelial–mesenchymal transition (EMT). Specifically, both drugs protected against CdtB-induced EMT features, including increased nuclear accumulation of SNAIL, enhanced matrix degradation, and motility. Overall, these data show that infection with genotoxin-producing bacteria promotes key EMT features through β‑catenin and AKT-dependent signaling.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: